SlideShare ist ein Scribd-Unternehmen logo
1 von 31
Dr. Muhammad Asim Rana
MBBS, MRCP(UK), FCCP, SF-CCM
, EDIC
Critical Care Medicine
• Bed no 1 is a 68 yrs old chronic case for
tracheostomy and the Hb% is 8.5
• ENT and Ansthesia has demanded Hb% of
10.0
• What will you do?
PRBCs Ideal for patients requiring red cells
but not volume replacement. Increase
O2 carrying capacity
• Transfusion trigger (HCT<30% ;

HB<10g/dl)
• 1 Unit increases 3% HCT or 1g/dl

• Shelf life =42 d (1-6 ℃)
• Bed no 14 Medical ICU, a 35 yrs old
female case of Sickle Cell Anemia has
been admitted with chest pain and
cough, has anemia Hb% is 6.0, your
consultant advised therapeutic exchange.
• What will be your plan?
• Bed no 34 surgical ICU, a 25 yrs old male
victim of RTA admitted with severe abdominal
injury with ruptured spleen and tear in liver is
admitted post OR.
• His Hb% pre OR was 3.0 he received 10
PRBCs in OR as he was massively bleeding
during surgery
• Came hypotensive, hypothermic, oozing from
wounds and active bloody out put from drains
• What will be your plan?
• His resuscitation started with PPF, Hessteril and PRBCs but his bleeding is not
stopped
• GS has no plan to re-explore him
• His labs showed that he is in severe DIC
• Why?
• What is the solution now?
• Bed no 50 surgical ICU, a 55 yrs old male
ESRD on haemodialysis admitted post
fixation of his fracture femur.
• You found he has a constant ooz from the
incision so that his Hb% dropped to 6.0
• What will be your plan?
• What is the cause of constant oozing in
this pt?
• Bed no 23 a 65 yrs old female, case of
hydrocephalus due to TBM is going for
EVD insertion and you see that she has
very low platlets around 30,000
(thrombocytopenia)
• What will be your plan?
• What is the risk in this pt?
• Consists of formed elements (cells)
suspended & carried in plasma (fluid part)
• Total blood volume is about 5L
• Plasma is straw-colored liquid consisting of
H20 & dissolved solutes
• Includes
ions, metabolites, hormones, antibodies
PRBCs Ideal for patients requiring red cells but not volume replacement.
Increase O2 carrying capacity
Transfusion trigger (HCT<30% ; HB<10g/dl)
1 Unit increases 3% HCT or 1g/dl
Shelf life =42 d (1-6 ℃)

Platelets
Thrombocytopenia (< 5,000)
Platelet dysfunction
Each unit increase 5,000 PLTs after 1hr

FFP ( initial therapeutic dose : 10-15 ml/kg ) and used in
Isolated factor deficiencies
Reverse warfarin therapy
Correction of coagulopathy associated with liver disease
Massive blood transfusion with microvascular bleeding
(>1 BV/ 24 hrs or > 50 % BV within 3 hrs or > 150 ml/min)

Antithrombin III deficiency
TTP ( Thrombotic thrombocytopenic purpura )
Christian Zagado (1665)
First human blood transfusion
Dr. James Blundell, a British
obstetrician (1825)

Austrian Karl Landsteiner (1900)

Discovery of ABO type

Oswald Hope Robertson
US Army Capt 1916
First Blood Bank World War 1
Erythrocytes (RBCs)
• RBCs are flattened biconcave discs
• Shape provides increased surface area
for diffusion
• Lack nuclei & mitochondria
• Each RBC contains 280 million
hemoglobins

13-9
• Have nucleus, mitochondria, & amoeboid ability
• Granular leukocytes help detoxify foreign substances & release
heparin

• Include eosinophils, basophils, & neutrophils

• Agranular leukocytes are
phagocytic

& produce antibodies

,Include

lymphocytes &

monocytes

13-10
• Are smallest of formed elements, lack
nucleus
• Are fragments of megakaryocytes
• Constitute most of mass of blood clots
• Release serotonin to vasoconstrict &
reduce
blood flow to clot area
• Secrete growth factors to maintain
integrity of blood vessel wall
• Survive 5-9 days

13-12
• Constitute 7-9% of the plasma
• Three types : albumins, globulins, & fibrinogen
Albumin accounts for 60-80%
• Creates colloid osmotic pressure that draws H20
from interstitial fluid into capillaries to maintain blood
volume & pressure

Globulins carry lipids. Gamma globulins are
antibodies
Fibrinogen serves as clotting factor
Serum is fluid left when blood clots
13-8


Whole Blood;



Blood Component;RBC PLT FFP Leukocyte
concentrate



Plasma Substitutes;

Use of whole blood is considered to be waste of
resources
Indications
•

Acute massive blood loss;

•

Anaemia and hypoalbuminemia

•

Overwhelming Infection

•

Dysfunction of Coagulation;


Approach Route: PVL, CVL



Filtration before Transfusion



Velocity of Transfusion: 5-10ml/min



Double Check: Name, Type and Cross-match



Storage Time



Pre-heat



No any other Medication



Observation during / after Transfusion
• The pt of bed 1 is receiving 2 units of PRBCs for
possible tracheostomy. After his 1st unit of blood he
developed a temp of 38.3 °C (101.0°F). He has no other
symptoms.
On exam he appears anxious but his vital signs are
stable with BP 120/70mmHg, HR 80bpm RR18 Sat O2
98% on Room Air
he has no skin rash and his urine color is amber
What is your diagnosis?
How would you manage this patient ?
•
•

Most common, usually benign without sequelae
Concerning because initial presentation is similar to
more adverse reactions. i.e. fever, chills +/- mild
dyspnea.
15% will have a recurrence in the future with
subsequent transfusion

•

Management
•
•
•

Discontinue transfusion, rule out hemolysis i.e.
check labels, repeat type and cross
match, coombs test
Antipyretics +/- meperidine for chills and rigors
Although antihistamine premedication is widely
used there are no evidence to support that their
use actually prevents reaction.
• A 35-year-old woman with sickle cell disease, she is
receiving 2 units of PRBC. Her 1st unit of blood was
transfused without events but 5minutes into her 2nd
unit, She complains of new flank pain and fever.
On exam she appears very anxious, diaphoretic and in
acute distress, she is febrile to 38.8C with BP
100/60mmHg, HR101/m RR 22/m, Pulse Ox 98% 0n RA
She has no skin rash but is oozing out of IV sites and her
urine color is now reddish brown.
Labs: elevated Bun/creat, increased PTT, PT and
decreased HCT.
What is the diagnosis and how would you manage this
patient?
• Medical emergency
• Occurs due to rapid transfused RBC destruction by
preformed recipients Abs
• Mostly due to ABO incompatibility
• Most common causes are clerical or procedural errors
• Complications includes DIC, shock, ARF secondary to
ATN

Clinical presentation

• Classic presenting triad of Fever, flank pain and
reddish brown urine from hemoglobinuria are rarely
seen
• DIC may be presenting mode
• Positive Direct Coombs
• People with Type A blood
make antibodies to Type
B RBCs, but not to Type
A
• Type B blood has
antibodies to Type A
RBCs but not to Type B
• Type AB blood doesn’t
have antibodies to A or B
• Type O has antibodies to
both Type A & B
• If different blood types
are mixed, antibodies will
cause mixture to
• If blood types don't
match, recipient’s
antibodies agglutinate
donor’s RBCs
• Type O is “universal
donor” because lacks A
& B antigens
• Recipient’s antibodies
won’t agglutinate donor’s
Type O RBCs

• Type AB is “universal
recipient” because
doesn’t make anti-A or
anti-B antibodies
• Won’t agglutinate donor’s

Insert fig. 13.6 •
Management
1. Stop transfusion, alert blood bank to start search for
clerical error since another patient may be at risk

, repeat type and cross matching
2. Supportive care; ABC +/-pressors
3. Cardiac monitoring because of risk of hyperkalemia

4. Infuse N/S to maintain BP and promote diuresis, avoid
LR and dextrose because calcium in LR will promote
clotting in IV line and dextrose will increase hemolysis.

Maintain urine output >100-200ml/hour
5. With DIC early heparinization 10u/kg/hr may be
beneficial
life threatening emergency
•Occurs within a few seconds to minutes

following transfusion
•Characterized by rapid onset of anaphylaxis
•Can occur with all blood products
•Incidence ; 1 in 20-50 thousand
•Presence of class specific IgG and anti IgA abs

in patients who are IgA deficient
•Treatment: Epinephrine , ABC +/- pressor
After 3days of treatment, he had improved however, he developed a
cough and a temperature of 38.3°C , with increasing FiO2 requirement
O/E, BP is 120/80 mm Hg. There is no rash . he is tachycardic . Oxygen
saturation is 80% on FiO2 of 85%, and a blood gas study shows an
arterial PO2 of 45 mm Hg. A chest radiograph reveals diffuse
opacifications of both lungs.
Which of the following is the most likely cause for this patient's
reaction?
1. Pulmonary embolism

2. Antileukocyte antibodies
3. Allergy to donor plasma proteins
4. Circulatory overload
• New acute lung injury occurring during or within 6 hour of blood
product transfusion
• 1 case for every 1000-2400 units transfused with 6-9% mortality rate
• Abs against HLA

Clinical presentation
• Acute onset of respiratory distress (hypoxemia) during or shortly after
blood transfusion.
• Fever, tachycardia, tachypnea, +/-hypotension
• In intubated pts; elevated peak airway pressures, pink frothy airway
secretion
• CXR bilateral patchy alveolar infiltrates, normal cardiac picture

Management
• Mostly supportive with abrupt resolution in symptoms within a few
days
• A majority of patients may require mechanical ventilation
Immune mediated transfusion reactions
• Febrile non hemolytic transfusion
reactions
• Acute and delayed hemolytic reactions
• Anaphylactic transfusion reaction
• Urticarial transfusion reaction
• Post-transfusion purpura
• GVHD
• TRALI (Transfusion Related Acute Lung
Injury)
• Physical reactions: thermal i.e. heat or cold
induced

• Infectious; Hepatitis B/C, malaria, HIV, CMV, West
Nile virus

• Chemical; citrate toxicity, hypo/hyperkalemia, iron
overload

• Acute hypotensive reaction: mediated by
bradykinins and occurs in patients with faulty
bradykinin metabolism on ACE I

• Osmotic injury
• Transfusion reactions are mostly due to
documentation errors and can range from benign
reactions to life threatening emergencies
• Early detection, discontinuation of transfusion
and instituting supportive care are key to
management.
• Reporting of all reactions helps to improve
standard practices and reduce future
occurrences.
Dr. Asim Rana

Weitere ähnliche Inhalte

Was ist angesagt?

CME-Cryoprecipitate.ppt22mar
CME-Cryoprecipitate.ppt22marCME-Cryoprecipitate.ppt22mar
CME-Cryoprecipitate.ppt22mar
Hwee Yin Wong
 

Was ist angesagt? (20)

AUTOLOGOUS BLOOD TRANSFUSION
AUTOLOGOUS BLOOD TRANSFUSIONAUTOLOGOUS BLOOD TRANSFUSION
AUTOLOGOUS BLOOD TRANSFUSION
 
Transfusion therapy
Transfusion therapyTransfusion therapy
Transfusion therapy
 
Blood and blood transfusion
Blood and blood transfusionBlood and blood transfusion
Blood and blood transfusion
 
Rational use of blood
Rational use of bloodRational use of blood
Rational use of blood
 
Transfusion related acute lung injury
Transfusion related acute lung injuryTransfusion related acute lung injury
Transfusion related acute lung injury
 
blood component therapy
blood component therapyblood component therapy
blood component therapy
 
Blood transfusion reaction
Blood transfusion reactionBlood transfusion reaction
Blood transfusion reaction
 
Adverse Effects Of Blood Transfusion
Adverse Effects Of Blood TransfusionAdverse Effects Of Blood Transfusion
Adverse Effects Of Blood Transfusion
 
Blood transfusion reactions
Blood transfusion reactionsBlood transfusion reactions
Blood transfusion reactions
 
Blood transfusion guidelines in clinical practice
Blood transfusion guidelines in clinical practiceBlood transfusion guidelines in clinical practice
Blood transfusion guidelines in clinical practice
 
Blood components and its uses
Blood components and its usesBlood components and its uses
Blood components and its uses
 
Blood transfusion - components , procedure , pre transfusion testing and comp...
Blood transfusion - components , procedure , pre transfusion testing and comp...Blood transfusion - components , procedure , pre transfusion testing and comp...
Blood transfusion - components , procedure , pre transfusion testing and comp...
 
CME-Cryoprecipitate.ppt22mar
CME-Cryoprecipitate.ppt22marCME-Cryoprecipitate.ppt22mar
CME-Cryoprecipitate.ppt22mar
 
blood, blood product, blood transfusion
blood, blood product, blood transfusionblood, blood product, blood transfusion
blood, blood product, blood transfusion
 
Crossmatching
CrossmatchingCrossmatching
Crossmatching
 
Autologous Blood Transfusion
Autologous Blood TransfusionAutologous Blood Transfusion
Autologous Blood Transfusion
 
Autoimmune hemolytic anemia
Autoimmune hemolytic anemiaAutoimmune hemolytic anemia
Autoimmune hemolytic anemia
 
Blood transfusion reactions
Blood transfusion reactionsBlood transfusion reactions
Blood transfusion reactions
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
Blood component therapy and blood substitutes
Blood component therapy and blood substitutes Blood component therapy and blood substitutes
Blood component therapy and blood substitutes
 

Ähnlich wie Blood components and transfusion reactions

Indications and complications of blood transfusion
Indications and complications of blood transfusion Indications and complications of blood transfusion
Indications and complications of blood transfusion
abhimanyu_ganguly
 
7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt
RyanJayAbolencia1
 
Blood groups,blood components and blood transfusion By Dr Bimalesh Kumar Gupta
Blood groups,blood components and blood transfusion By Dr Bimalesh Kumar GuptaBlood groups,blood components and blood transfusion By Dr Bimalesh Kumar Gupta
Blood groups,blood components and blood transfusion By Dr Bimalesh Kumar Gupta
Drbimalesh Gupta
 

Ähnlich wie Blood components and transfusion reactions (20)

Blood Transfusion
Blood TransfusionBlood Transfusion
Blood Transfusion
 
Transfusion Medicine
Transfusion MedicineTransfusion Medicine
Transfusion Medicine
 
BloodTransfussionGuidelines.pdf
BloodTransfussionGuidelines.pdfBloodTransfussionGuidelines.pdf
BloodTransfussionGuidelines.pdf
 
Blood
BloodBlood
Blood
 
Blood and blood products.pptx
Blood and blood products.pptxBlood and blood products.pptx
Blood and blood products.pptx
 
Bl.therapy2012
Bl.therapy2012Bl.therapy2012
Bl.therapy2012
 
Indications and complications of blood transfusion
Indications and complications of blood transfusion Indications and complications of blood transfusion
Indications and complications of blood transfusion
 
5 blood trasfusioin and its hazards
5 blood trasfusioin and its hazards5 blood trasfusioin and its hazards
5 blood trasfusioin and its hazards
 
5 blood trasfusioin and its hazards
5 blood trasfusioin and its hazards5 blood trasfusioin and its hazards
5 blood trasfusioin and its hazards
 
blood and blood products
blood and blood productsblood and blood products
blood and blood products
 
bloodtransfusionandtransfusionreactions-170124162247.pdf
bloodtransfusionandtransfusionreactions-170124162247.pdfbloodtransfusionandtransfusionreactions-170124162247.pdf
bloodtransfusionandtransfusionreactions-170124162247.pdf
 
Dr. rasel cme final
Dr. rasel cme   finalDr. rasel cme   final
Dr. rasel cme final
 
7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt
 
7.-Peter-Hudson-Blood-transfusion (1).ppt
7.-Peter-Hudson-Blood-transfusion (1).ppt7.-Peter-Hudson-Blood-transfusion (1).ppt
7.-Peter-Hudson-Blood-transfusion (1).ppt
 
7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt7.-Peter-Hudson-Blood-transfusion.ppt
7.-Peter-Hudson-Blood-transfusion.ppt
 
Blood groups,blood components and blood transfusion By Dr Bimalesh Kumar Gupta
Blood groups,blood components and blood transfusion By Dr Bimalesh Kumar GuptaBlood groups,blood components and blood transfusion By Dr Bimalesh Kumar Gupta
Blood groups,blood components and blood transfusion By Dr Bimalesh Kumar Gupta
 
Blood transfusion
Blood  transfusionBlood  transfusion
Blood transfusion
 
Blood Transfusion - Final work.pptx
Blood Transfusion - Final work.pptxBlood Transfusion - Final work.pptx
Blood Transfusion - Final work.pptx
 
Blood component therapy
Blood component therapy  Blood component therapy
Blood component therapy
 
Blood_Transfusion-presentation.ppt
Blood_Transfusion-presentation.pptBlood_Transfusion-presentation.ppt
Blood_Transfusion-presentation.ppt
 

Mehr von Muhammad Asim Rana

The best use of systemic corticosteroids in the intensive care units, review
The best use of systemic corticosteroids in the intensive care units, reviewThe best use of systemic corticosteroids in the intensive care units, review
The best use of systemic corticosteroids in the intensive care units, review
Muhammad Asim Rana
 

Mehr von Muhammad Asim Rana (20)

ICU management of ECMO pt
ICU management of ECMO ptICU management of ECMO pt
ICU management of ECMO pt
 
Basal ganglia stroke
Basal ganglia strokeBasal ganglia stroke
Basal ganglia stroke
 
Vertebral artery injury with dialysis catheter
Vertebral artery injury with dialysis catheterVertebral artery injury with dialysis catheter
Vertebral artery injury with dialysis catheter
 
Dysphagia lusoria
Dysphagia lusoriaDysphagia lusoria
Dysphagia lusoria
 
From eye drops to icu, a case report of three side effects of ophthalmic timo...
From eye drops to icu, a case report of three side effects of ophthalmic timo...From eye drops to icu, a case report of three side effects of ophthalmic timo...
From eye drops to icu, a case report of three side effects of ophthalmic timo...
 
Congenitally absent Inferior Vena Cava: A rare cause of recurrent DVT and non...
Congenitally absent Inferior Vena Cava: A rare cause of recurrent DVT and non...Congenitally absent Inferior Vena Cava: A rare cause of recurrent DVT and non...
Congenitally absent Inferior Vena Cava: A rare cause of recurrent DVT and non...
 
The best use of systemic corticosteroids in the intensive care units, review
The best use of systemic corticosteroids in the intensive care units, reviewThe best use of systemic corticosteroids in the intensive care units, review
The best use of systemic corticosteroids in the intensive care units, review
 
Clabsi bundle audit
Clabsi bundle auditClabsi bundle audit
Clabsi bundle audit
 
Time between decision to admit and icu arrival of patients from emergency dep...
Time between decision to admit and icu arrival of patients from emergency dep...Time between decision to admit and icu arrival of patients from emergency dep...
Time between decision to admit and icu arrival of patients from emergency dep...
 
Case discussion calcium abnormalities (final)
Case discussion calcium abnormalities (final)Case discussion calcium abnormalities (final)
Case discussion calcium abnormalities (final)
 
Fungal diseases intensivist should know
Fungal diseases intensivist should knowFungal diseases intensivist should know
Fungal diseases intensivist should know
 
Hypokalemia in ICU
Hypokalemia in ICUHypokalemia in ICU
Hypokalemia in ICU
 
Plasmapheresis in ICU
Plasmapheresis in ICUPlasmapheresis in ICU
Plasmapheresis in ICU
 
Transorbital stab injury with retained knife. A narrow escape
Transorbital stab injury with retained knife. A narrow escapeTransorbital stab injury with retained knife. A narrow escape
Transorbital stab injury with retained knife. A narrow escape
 
Intrpleural colistin
Intrpleural colistinIntrpleural colistin
Intrpleural colistin
 
MERS CoV Prevention
MERS CoV PreventionMERS CoV Prevention
MERS CoV Prevention
 
Hepatorenal Syndrome
Hepatorenal SyndromeHepatorenal Syndrome
Hepatorenal Syndrome
 
Heat Stroke
Heat Stroke Heat Stroke
Heat Stroke
 
Iron toxicity
Iron toxicityIron toxicity
Iron toxicity
 
Vap bundle compliance in icu
Vap bundle compliance in icuVap bundle compliance in icu
Vap bundle compliance in icu
 

Kürzlich hochgeladen

Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
AnaAcapella
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 

Kürzlich hochgeladen (20)

Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 

Blood components and transfusion reactions

  • 1. Dr. Muhammad Asim Rana MBBS, MRCP(UK), FCCP, SF-CCM , EDIC Critical Care Medicine
  • 2. • Bed no 1 is a 68 yrs old chronic case for tracheostomy and the Hb% is 8.5 • ENT and Ansthesia has demanded Hb% of 10.0 • What will you do?
  • 3. PRBCs Ideal for patients requiring red cells but not volume replacement. Increase O2 carrying capacity • Transfusion trigger (HCT<30% ; HB<10g/dl) • 1 Unit increases 3% HCT or 1g/dl • Shelf life =42 d (1-6 ℃)
  • 4. • Bed no 14 Medical ICU, a 35 yrs old female case of Sickle Cell Anemia has been admitted with chest pain and cough, has anemia Hb% is 6.0, your consultant advised therapeutic exchange. • What will be your plan?
  • 5. • Bed no 34 surgical ICU, a 25 yrs old male victim of RTA admitted with severe abdominal injury with ruptured spleen and tear in liver is admitted post OR. • His Hb% pre OR was 3.0 he received 10 PRBCs in OR as he was massively bleeding during surgery • Came hypotensive, hypothermic, oozing from wounds and active bloody out put from drains • What will be your plan?
  • 6. • His resuscitation started with PPF, Hessteril and PRBCs but his bleeding is not stopped • GS has no plan to re-explore him • His labs showed that he is in severe DIC • Why? • What is the solution now?
  • 7. • Bed no 50 surgical ICU, a 55 yrs old male ESRD on haemodialysis admitted post fixation of his fracture femur. • You found he has a constant ooz from the incision so that his Hb% dropped to 6.0 • What will be your plan? • What is the cause of constant oozing in this pt?
  • 8. • Bed no 23 a 65 yrs old female, case of hydrocephalus due to TBM is going for EVD insertion and you see that she has very low platlets around 30,000 (thrombocytopenia) • What will be your plan? • What is the risk in this pt?
  • 9. • Consists of formed elements (cells) suspended & carried in plasma (fluid part) • Total blood volume is about 5L • Plasma is straw-colored liquid consisting of H20 & dissolved solutes • Includes ions, metabolites, hormones, antibodies
  • 10. PRBCs Ideal for patients requiring red cells but not volume replacement. Increase O2 carrying capacity Transfusion trigger (HCT<30% ; HB<10g/dl) 1 Unit increases 3% HCT or 1g/dl Shelf life =42 d (1-6 ℃) Platelets Thrombocytopenia (< 5,000) Platelet dysfunction Each unit increase 5,000 PLTs after 1hr FFP ( initial therapeutic dose : 10-15 ml/kg ) and used in Isolated factor deficiencies Reverse warfarin therapy Correction of coagulopathy associated with liver disease Massive blood transfusion with microvascular bleeding (>1 BV/ 24 hrs or > 50 % BV within 3 hrs or > 150 ml/min) Antithrombin III deficiency TTP ( Thrombotic thrombocytopenic purpura )
  • 11. Christian Zagado (1665) First human blood transfusion Dr. James Blundell, a British obstetrician (1825) Austrian Karl Landsteiner (1900) Discovery of ABO type Oswald Hope Robertson US Army Capt 1916 First Blood Bank World War 1
  • 12. Erythrocytes (RBCs) • RBCs are flattened biconcave discs • Shape provides increased surface area for diffusion • Lack nuclei & mitochondria • Each RBC contains 280 million hemoglobins 13-9
  • 13. • Have nucleus, mitochondria, & amoeboid ability • Granular leukocytes help detoxify foreign substances & release heparin • Include eosinophils, basophils, & neutrophils • Agranular leukocytes are phagocytic & produce antibodies ,Include lymphocytes & monocytes 13-10
  • 14. • Are smallest of formed elements, lack nucleus • Are fragments of megakaryocytes • Constitute most of mass of blood clots • Release serotonin to vasoconstrict & reduce blood flow to clot area • Secrete growth factors to maintain integrity of blood vessel wall • Survive 5-9 days 13-12
  • 15. • Constitute 7-9% of the plasma • Three types : albumins, globulins, & fibrinogen Albumin accounts for 60-80% • Creates colloid osmotic pressure that draws H20 from interstitial fluid into capillaries to maintain blood volume & pressure Globulins carry lipids. Gamma globulins are antibodies Fibrinogen serves as clotting factor Serum is fluid left when blood clots 13-8
  • 16.  Whole Blood;  Blood Component;RBC PLT FFP Leukocyte concentrate  Plasma Substitutes; Use of whole blood is considered to be waste of resources Indications • Acute massive blood loss; • Anaemia and hypoalbuminemia • Overwhelming Infection • Dysfunction of Coagulation;
  • 17.  Approach Route: PVL, CVL  Filtration before Transfusion  Velocity of Transfusion: 5-10ml/min  Double Check: Name, Type and Cross-match  Storage Time  Pre-heat  No any other Medication  Observation during / after Transfusion
  • 18. • The pt of bed 1 is receiving 2 units of PRBCs for possible tracheostomy. After his 1st unit of blood he developed a temp of 38.3 °C (101.0°F). He has no other symptoms. On exam he appears anxious but his vital signs are stable with BP 120/70mmHg, HR 80bpm RR18 Sat O2 98% on Room Air he has no skin rash and his urine color is amber What is your diagnosis? How would you manage this patient ?
  • 19. • • Most common, usually benign without sequelae Concerning because initial presentation is similar to more adverse reactions. i.e. fever, chills +/- mild dyspnea. 15% will have a recurrence in the future with subsequent transfusion • Management • • • Discontinue transfusion, rule out hemolysis i.e. check labels, repeat type and cross match, coombs test Antipyretics +/- meperidine for chills and rigors Although antihistamine premedication is widely used there are no evidence to support that their use actually prevents reaction.
  • 20. • A 35-year-old woman with sickle cell disease, she is receiving 2 units of PRBC. Her 1st unit of blood was transfused without events but 5minutes into her 2nd unit, She complains of new flank pain and fever. On exam she appears very anxious, diaphoretic and in acute distress, she is febrile to 38.8C with BP 100/60mmHg, HR101/m RR 22/m, Pulse Ox 98% 0n RA She has no skin rash but is oozing out of IV sites and her urine color is now reddish brown. Labs: elevated Bun/creat, increased PTT, PT and decreased HCT. What is the diagnosis and how would you manage this patient?
  • 21. • Medical emergency • Occurs due to rapid transfused RBC destruction by preformed recipients Abs • Mostly due to ABO incompatibility • Most common causes are clerical or procedural errors • Complications includes DIC, shock, ARF secondary to ATN Clinical presentation • Classic presenting triad of Fever, flank pain and reddish brown urine from hemoglobinuria are rarely seen • DIC may be presenting mode • Positive Direct Coombs
  • 22. • People with Type A blood make antibodies to Type B RBCs, but not to Type A • Type B blood has antibodies to Type A RBCs but not to Type B • Type AB blood doesn’t have antibodies to A or B • Type O has antibodies to both Type A & B • If different blood types are mixed, antibodies will cause mixture to
  • 23. • If blood types don't match, recipient’s antibodies agglutinate donor’s RBCs • Type O is “universal donor” because lacks A & B antigens • Recipient’s antibodies won’t agglutinate donor’s Type O RBCs • Type AB is “universal recipient” because doesn’t make anti-A or anti-B antibodies • Won’t agglutinate donor’s Insert fig. 13.6 •
  • 24. Management 1. Stop transfusion, alert blood bank to start search for clerical error since another patient may be at risk , repeat type and cross matching 2. Supportive care; ABC +/-pressors 3. Cardiac monitoring because of risk of hyperkalemia 4. Infuse N/S to maintain BP and promote diuresis, avoid LR and dextrose because calcium in LR will promote clotting in IV line and dextrose will increase hemolysis. Maintain urine output >100-200ml/hour 5. With DIC early heparinization 10u/kg/hr may be beneficial
  • 25. life threatening emergency •Occurs within a few seconds to minutes following transfusion •Characterized by rapid onset of anaphylaxis •Can occur with all blood products •Incidence ; 1 in 20-50 thousand •Presence of class specific IgG and anti IgA abs in patients who are IgA deficient •Treatment: Epinephrine , ABC +/- pressor
  • 26. After 3days of treatment, he had improved however, he developed a cough and a temperature of 38.3°C , with increasing FiO2 requirement O/E, BP is 120/80 mm Hg. There is no rash . he is tachycardic . Oxygen saturation is 80% on FiO2 of 85%, and a blood gas study shows an arterial PO2 of 45 mm Hg. A chest radiograph reveals diffuse opacifications of both lungs. Which of the following is the most likely cause for this patient's reaction? 1. Pulmonary embolism 2. Antileukocyte antibodies 3. Allergy to donor plasma proteins 4. Circulatory overload
  • 27. • New acute lung injury occurring during or within 6 hour of blood product transfusion • 1 case for every 1000-2400 units transfused with 6-9% mortality rate • Abs against HLA Clinical presentation • Acute onset of respiratory distress (hypoxemia) during or shortly after blood transfusion. • Fever, tachycardia, tachypnea, +/-hypotension • In intubated pts; elevated peak airway pressures, pink frothy airway secretion • CXR bilateral patchy alveolar infiltrates, normal cardiac picture Management • Mostly supportive with abrupt resolution in symptoms within a few days • A majority of patients may require mechanical ventilation
  • 28. Immune mediated transfusion reactions • Febrile non hemolytic transfusion reactions • Acute and delayed hemolytic reactions • Anaphylactic transfusion reaction • Urticarial transfusion reaction • Post-transfusion purpura • GVHD • TRALI (Transfusion Related Acute Lung Injury)
  • 29. • Physical reactions: thermal i.e. heat or cold induced • Infectious; Hepatitis B/C, malaria, HIV, CMV, West Nile virus • Chemical; citrate toxicity, hypo/hyperkalemia, iron overload • Acute hypotensive reaction: mediated by bradykinins and occurs in patients with faulty bradykinin metabolism on ACE I • Osmotic injury
  • 30. • Transfusion reactions are mostly due to documentation errors and can range from benign reactions to life threatening emergencies • Early detection, discontinuation of transfusion and instituting supportive care are key to management. • Reporting of all reactions helps to improve standard practices and reduce future occurrences.

Hinweis der Redaktion

  1. AGE BLOOD VOLUME Neonates Premature 95 ml/kg Full-term 85 ml/kg Infants 80 ml/kg Adults Men 75 ml/kg Women 65 ml/kg
  2. Can squeeze through capillary walls (diapedesis)
  3. AGE BLOOD VOLUME Neonates Premature 95 ml/kg Full-term 85 ml/kg Infants 80 ml/kg Adults Men 75 ml/kg Women 65 ml/kg
  4. The human leukocyte antigen (HLA) systemPrevention Leukoreduction: evidence is scarce but few studies have shown a decrease in number of reactions. Although tylenol and antihistamine premedication is widely used there are no evidence to support that their use actually prevents rxn.
  5. Human red cell membrane : least 300 different antigenfortunately, only the ABO and the Rh systems are important in the majority of blood transfusionHistoryHct. Infection : Hepatitis B,C syphillis HIV-1,2 HTLV-I,II
  6. Selective IgA def is fairly common, occurring in 1/300-500 people but majority of them do not develop Abs -Ahaptoglobinemia with antihaptoglobin Abs is similar and occur primarily in East Asian
  7. 1st hit is an underlying pulm pathology that leads to localization of neutrophils in the pulm vasculature 2nd hit is the transfusion of blood products containing sensitized neutrophilsAb leading to release of vasoactive Cytokine and pulm edemaLabs; eosinophilia and transient drop in neutrophils, Leuko-agglutinin testingAcute onset of respiratory distress (hypoxemia) during or shortly after blood tranx. On the average within 1-2 hours post tranxFever, tachycardia, tachypnea, +/-hypotension In intubatedpxts; elevated peak airway pressures, pink frothy airway secretion CXR bilateral patchy alveolar infiltrates, normal cardiac pictureLabs; eosinophilia and transient drop in neutrophils, Leuko-agglutinin testingDiagnosisClinical presentation and CXR findings-Labs; granulocyte/ leuko-agglutinating abs, decline in C3 or C5 levels 12-36 hours after onset of symptoms followed by rise 4-7 days later
  8. Ddx includesAcute fluid overload: ↑ JVP, ↑SBP and widened pulse pressure during dyspneic episode, ↑ pulm vascular markings on CXRHemolytic transfusion rxnsIgA mediated anaphylaxis in IgA def patientsManagement-Mostly supportive with abrupt resolution in symptoms within a few days-A majority of patients may require mechanical ventilation-Diuretics play no role in management since it is microvascular damage and not due to volume. It has been shown to actually worsen TRALIPrognosisIncreased risk of recurrence if they receive products from the implicated donor but no risk from other donors